https://www.healio.com/family-medicine/practice-management/news/online/%7B13343b09-c952-4df5-a3b0-22b840ff8f97%7D/fda-expands-marketing-of-23andme-to-include-medication-metabolism
23 and Me
The FDA expanded the approved marketing of the 23andMe Personal Genome Service Pharmacogenetic Reports test to include information about 33 genetic variants that may be linked with a patient’s ability to metabolize some medications to help inform discussions with a health care provider, according to an agency press release.